
July to September 2024
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| PEMBROLIZUMAB | $169,059,341 | 19,931 |
| ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR | $146,331,684 | 6,844 |
| USTEKINUMAB | $123,408,310 | 17,388 |
| AFLIBERCEPT | $112,051,746 | 114,831 |
| DUPILUMAB | $111,674,084 | 65,065 |
| NIVOLUMAB | $110,127,647 | 15,313 |
| SEMAGLUTIDE | $80,922,148 | 674,942 |
| APIXABAN | $77,642,890 | 1,083,852 |
| DENOSUMAB | $74,485,911 | 294,133 |
| UPADACITINIB | $65,944,134 | 45,680 |
| MOLNUPIRAVIR | $63,847,963 | 52,327 |
| OCRELIZUMAB | $59,320,256 | 3,622 |
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ROSUVASTATIN | $33,588,345 | 4,126,017 |
| ATORVASTATIN | $26,311,510 | 2,877,860 |
| PANTOPRAZOLE | $25,379,489 | 2,825,842 |
| ESOMEPRAZOLE | $20,770,190 | 2,078,426 |
| ESCITALOPRAM | $8,154,493 | 1,667,966 |
| PERINDOPRIL | $13,072,931 | 1,653,554 |
| AMOXICILLIN | $6,636,166 | 1,592,178 |
| METFORMIN | $13,929,204 | 1,582,048 |
| SERTRALINE | $8,400,582 | 1,579,952 |
| CEFALEXIN | $7,677,207 | 1,300,636 |
| AMLODIPINE | $10,202,995 | 1,215,666 |
| APIXABAN | $77,642,890 | 1,083,852 |
| Contributor | Contribution Dollars |
|---|---|
| Australian Government | $4,847,250,970 |
| Patients | $888,085,245 |